hENT1’s role in adjuvant intra-arterial gemcitabine-based chemotherapy for resectable pancreatic cancer patients

BACKGROUND: We aimed to verify the role of hENT1 as a prognostic predictor for patients with resectable pancreatic ductal adenocarcinoma (PDAC) who underwent radical resection followed by intra-arterial infusion of gemcitabine-based regimen. METHODS: We collected surgical samples from 102 patients w...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Wei, Yu, Xinzhe, Li, Hengchao, Yang, Chuanxin, Jin, Chen, Huang, Xinyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9909848/
https://www.ncbi.nlm.nih.gov/pubmed/36755224
http://dx.doi.org/10.1186/s12876-023-02666-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9909848/
https://www.ncbi.nlm.nih.gov/pubmed/36755224
http://dx.doi.org/10.1186/s12876-023-02666-x

Ejemplares similares